MI-63 is a potent, specific, non-peptide inhibitor of the MDM2-p53 interaction. References: Drummond CJ, Esfandiari A, Liu J, Lu X, Hutton C, Jackson J, Bennaceur K, Xu Q, Makimanejavali AR, Del Bello F, Piergentili A, Newell DR, Hardcastle IR, Griffin RJ, Lunec J. TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation. Oncotarget. 2016 Jul 19;7(29):46203-46218. doi: 10.18632/oncotarget.10073. PubMed PMID: 27323823; PubMed Central PMCID: PMC5216791.

纯度：≥98%

CAS：908027-21-4